Activated macrophages inhibit human cytotrophoblast invasiveness in vitro

Biology of Reproduction

Volumn 73, Issue 2, 2005, Pages 237-243

  Renaud, Stephen J ^a   Postovit, Lynne Marie ^a   Macdonald Goodfellow, Shannyn K ^a   McDonald, Gail T ^a   Caldwell, Jason D ^a   Graham, Charles H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Cytokines; Immunology; Placenta; Pregnancy; Trophoblast

Indexed keywords

CASEIN; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROUROKINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTERIOLE; ARTICLE; CELL IMMORTALIZATION; CELL INVASION; CONTROLLED STUDY; CYTOTROPHOBLAST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MACROPHAGE ACTIVATION; MALE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR BINDING; TROPHOBLAST; UTERINE BLOOD VESSEL; UTERUS; ZYMOGRAPHY;

APOPTOSIS; CELL MOVEMENT; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA; URINARY PLASMINOGEN ACTIVATOR;

EID: 22544471215     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.104.038000     Document Type: Article

References (41)

1. Zeek PM, Assali NS. Vascular changes in decidua associated with eclamptogenic toxemia of pregnancy. Am J Clin Pathol 1950; 20: 1099-1109.
2. Brown MA. Pregnancy-induced hypertension: pathogenesis and management. Aust N Z J Med 1991; 21:257.
3. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93:1049-1059.
4. Robertson WB, Brosens I, Dixon G. Uteroplacental vascular pathology. Eur J Obstet Gynecol Reprod Biol 1975; 5:47-65.
5. Redman CWG. Current topic: pre-eclampsia and the placenta. Placenta 1991; 12:301-308.
6. Robertson SA, Bromfield JJ, Tremellen KP. Seminal 'priming' for protection from pre-eclampsia-a unifying hypothesis. J Reprod Immunol 2003; 59:253-265.
7. Robertson SA, Ingman WV, O'Leary S, Sharkey DJ, Tremellen KP. Transforming growth factor beta-a mediator of immune deviation in seminal plasma. J Reprod Immunol 2002; 57:109-128.
8. Dekker G. The partner's role in the etiology of preeclampsia. J Reprod Immunol 2002; 57:203-215.
9. Koelman CA, Coumans AB, Nijman HW, Doxiadis II, Dekker GA, Claas FH. Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? J Reprod Immunol 2000; 46:155-166.
10. Reister F, Frank HG, Heyl W, Kosanke G, Huppertz B, Schroder W, Kaufmann P, Rath W. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 1999; 20:229-233.
11. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001; 81:1143-1152.
12. Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous expiant cultures. J Clin Endocrinol Metab 2004; 89:812-822.
13. Kwaan HC. The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 1992; 11:291-311.
14. Ellis V, Behrendt N, Dano K. Plasminogen activation by receptor-bound urokinase. A kinetic study with cell associated and isolated receptor. J Biol Chem 1991; 266:12752-12758.
15. Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000; 57:25-40.
16. Knofler M, Stenzel M, Husslein P. Shedding of tumour necrosis factor receptors from purified villous term trophoblasts and cytotrophoblastic BeWo cells. Hum Reprod 1998; 13:2308-2316.
17. Gupta S. A decision between life and death during TNF-alpha-induced signaling. J Clin Immunol 2002; 22:185-194.
18. Li Y, Matsuzaki N, Masuhiro K, Kameda T, Taniguchi T, Saji F, Yone K, Tanizawa O. Trophoblast-derived tumor necrosis factor-alpha induces release of human chorionic gonadotropin using interleukin-6 (IL-6) and IL-6-receptor- dependent system in the normal human trophoblasts. J Clin Endocrinol Metab 1992; 74:184-191.
19. Monzon-Bordonaba F, Vadillo-Ortega F, Feinberg RF. Modulation of trophoblast function by tumor necrosis factor-alpha: a role in pregnancy establishment and maintenance? Am J Obstet Gynecol 2002; 187:1574-1580.
20. Meisser A, Chardonnens D, Campana A, Bischof P. Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Mol Hum Reprod 1999; 5:252-260.
21. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170:1752-1757.
22. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997; 37:240-249.
23. Casey ML, Cox SM, Beutler B, Milewich L, MacDonald PC. Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor. J Clin Invest 1989; 83:430-436.
24. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N, Lala PK. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 1993; 206:204-211.
25. Kilburn BA, Wang J, Duniec-Dmuchowski ZM, Leach RE, Romero R, Armant DR. Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line. Biol Reprod 2000; 62:739-747.
26. Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-β, IGF-II, and IGFBP-1. Exp Cell Res 1995; 217:419-427.
27. Current Protocols in Immunology. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds.), New York: John Wiley and Sons; 1992:7.6.1-7.6.7.
28. Tchou-Wong KM, Tanabe O, Chi C, Yie TA, Rom WN. Activation of NF-kappaB in Mycobacterium tuberculosis-induced interleukin-2 receptor expression in mononuclear phagocytes. Am J Respir Crit Care Med 1999; 159:1323-1329.
29. Williams DL, Lo JL, Amborski GF. Enrichment of T lymphocytes from bovine peripheral blood mononuclear cells using an immunoaffinity depletion technique ("panning"). Vet Immunol Immunopathol 1986; 11:199-204.
30. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992; 80:283-285.
31. Crocker IP, Cooper S, Ong SC, Baker PN. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003; 162:637-643.
32. Knofler M, Mosl B, Bauer S, Griesinger G, Husslein P. TNF-alpha/ TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta 2000; 21:525-535.
33. Pijnenborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983; 4:397-413.
34. Yedwab GA, Paz G, Homonnai TZ, David MP, Kraicer PF. The temperature, pH, and partial pressure of oxygen in the cervix and uterus of women and uterus of rats during the cycle. Fertil Steril 1976; 27: 304-309.
35. van Hinsbergh VW, Koolwijk P, Hanemaaijer R. Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells. EXS 1997; 79:391-411.
36. Graham CH, Forsdike J, Fitzgerald CF, Macdonald-Goodfellow S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 1999; 80: 617-623.
37. Vassalli JD, Belin D. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 1987; 214:187-191.
38. Kwaan HC, Wang J, Svoboda K, Declerck PJ. Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis. Br J Cancer 2000; 82:1702-1708.
39. Soeda S, Oda M, Ochiai T, Shimeno H. Deficient release of plasminogen activator inhibitor-1 from astrocytes triggers apoptosis in neuronal cells. Brain Res Mol Brain Res 2001; 91:96-103.
40. Chen Y, Kelm RJ Jr, Budd RC, Sobel BE, Schneider DJ. Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1. J Cell Biochem 2004; 92:178-188.
41. Postovit LM, Adams MA, Graham CH. Does nitric oxide play a role in the aetiology of pre-eclampsia? Placenta 2001; 22(suppl A):S51-S55.